SOPHiA GENETICS (SOPH) EBT (2020 - 2025)
Historic EBT for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$19.4 million.
- SOPHiA GENETICS's EBT fell 584.99% to -$19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.5 million, marking a year-over-year decrease of 236.65%. This contributed to the annual value of -$61.3 million for FY2024, which is 2194.41% up from last year.
- SOPHiA GENETICS's EBT amounted to -$19.4 million in Q3 2025, which was down 584.99% from -$21.7 million recorded in Q2 2025.
- SOPHiA GENETICS's EBT's 5-year high stood at -$12.5 million during Q1 2021, with a 5-year trough of -$25.3 million in Q1 2022.
- Its 5-year average for EBT is -$18.9 million, with a median of -$19.4 million in 2025.
- Per our database at Business Quant, SOPHiA GENETICS's EBT skyrocketed by 9980.17% in 2021 and then plummeted by 10214.52% in 2022.
- SOPHiA GENETICS's EBT (Quarter) stood at -$21.9 million in 2021, then soared by 35.03% to -$14.2 million in 2022, then plummeted by 69.05% to -$24.1 million in 2023, then surged by 39.54% to -$14.5 million in 2024, then plummeted by 33.26% to -$19.4 million in 2025.
- Its EBT was -$19.4 million in Q3 2025, compared to -$21.7 million in Q2 2025 and -$16.9 million in Q1 2025.